← Leaderboards
Ruben Niesvizky
Weill Medical College Of Cornell Univ
$630,956
Attributed
$630,956
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $173.2K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$630,956 · 4
By mechanism
K23$544,320 · 1
M01$86,636 · 3
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Ronald G Crystal$80,684,359
- Samie R Jaffrey$42,543,108
- George S Alexopoulos$38,685,557
- John P Moore$51,152,802
- Kyu Y Rhee$16,751,305
Others in their field
Top investigators on “Multiple Myeloma”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,380,351
- Larry Arthur$41,717,333
- Charles A Coltman · Southwest Oncology Group$36,988,659
- Kenneth C Anderson · Dana-Farber Cancer Inst$25,497,347
- Irene M. Ghobrial · Dana-Farber Cancer Inst$22,402,686
- Nilsa Del Carmen Ramirez · Ohio State University$22,287,552
Research focus
Multiple MyelomaRelapseNeoplasm /Cancer ChemotherapyClinical ResearchApoptosisClinical Trial Phase IiDrug Screening /EvaluationResourcesResearch PersonnelPurposeAntineoplasticsMalignant NeoplasmsRefractoryPatient Oriented ResearchHuman SubjectGenetic RegulationHuman Therapy EvaluationCell DeathFundingGenesGrantGrowthComputer Retrieval Of Information On Scientific Projects DatabaseDexamethasone
Grant awards (9)
EXPLOITING NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA (K23M)$136,080
K23 · FY2007 · CA · contact PI
VEGF TRAP FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA$662
M01 · FY2007 · RR · contact PI
A PHASE II STUDY OF DEPSIPEPTIDE IN PTS W/ RELAPSED/REFRACTORY MULTI MYELOMA$355
M01 · FY2007 · RR · contact PI
EXPLOITING NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA (K23M)$136,080
K23 · FY2006 · CA · contact PI
A PHASE II STUDY OF DEPSIPEPTIDE IN PTS W/ RELAPSED/REFRACTORY MULTI MYELOMA$36,461
M01 · FY2006 · RR · contact PI
EXPLOITING NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA (K23M)$136,080
K23 · FY2005 · CA
A PHASE II STUDY OF DEPSIPEPTIDE IN PTS W/ RELAPSED/REFRACTORY MULTI MYELOMA$37,168
M01 · FY2005 · RR
EXPLOITING NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA (K23M)$136,080
K23 · FY2004 · CA
Phase II Study of Depsipeptide in Pts. w/ Relapsed/Ref$11,990
M01 · FY2004 · RR